Studies examined the phenotypic characteristics of glutamate-induced cell death and their relationship to calpain and caspase-3 activation. Cell viability was assessed by fluo rescein diacetate and propidium iodide staining and lactate de hydrogenase release. Calpain and caspase-3 activity was in ferred from signature proteolytic fragmentation of a-spectrin. Characterization of cell death phenotypes was assessed by Hoechst 33258 and DNA fragmentation assays. Exposure of septohippocampal cultures to 1.0, 2.0, and 4.0 mmollL gluta mate induced a dose-dependent cell death with an LD50 of 2.0 mmollL glutamate after 24 hours of incubation. Glutamate treatment induced cell death in neurons and astroglia and pro duced morphological alterations that differed from necrotic or apoptotic changes observed after maitotoxin or staurosporine Previous studies have reported that excitotoxicity is associated primarily with necrosis (Choi et aI., 1987; Siman and Card, 1988) . More recent studies have main tained that both necrotic and apoptotic mechanisms are ----Abbreviations used: BDP, breakdown product; DMEM, Delbecco's modified Eagle's medium; FDA, fluorescein diacetate; GFAP, glial fibrillary acidic protein; LDH, lactate dehydrogenase; MAP-2, micro tubule-associated protein-2; NeuN, neuronal nuclear marker; NMDA, N-methyl-D-aspartate; PBS, phosphate-buffered saline; PI, propidium iodide; Z-D-DCB, carbobenzoxy-Asp-CH2-0C( 0)-2,6-dichloro benzene.
activated after excessive stimulation of various gluta mate receptor subtypes (Bonfoco et aI., 1995) . However, the precise mode of excitotoxic neuronal cell death re mains controversial. Inconsistent reports of cell death phenotypes produced specifically by glutamate toxicity in vitro have no doubt contributed to this controversy. For example, a number of investigators have reported glutamate-induced apoptotic-like cell death characteris tics in culture (Bonfoco et aI., 1995; Cebers et aI., 1997; Du et aI., 1997; Kure et aI., 1991) . In contrast, other investigators have concluded that glutamate toxicity does not produce apoptotic cell death profiles (Ikeda et al., 1996; MacManus et aI., 1997) . Comparison of data from these studies is complicated by the use of different cul ture systems, different criteria for defining apoptotic cell death phenotypes, and different glutamate dosing regi mens. Equally important, and with few exceptions (Du et aI., 1997; Nath et aI., 1998) , the possible contribution of MECHANISMS OF GLUTAMATE-INDUCED CELL DEATH 551 calpains and caspases as proteolytic mediators of ne crotic and apoptotic cell death has not been characterized in models of glutamate toxicity.
Caspases, members of the cysteine protease family, are important intracellular effectors of apoptosis in vari ous cell lines and apoptotic models (Nath et aI., 1996a,b; Pike et aI., 1998b; Zhivotovsky et aI., 1997) . The role of caspase-l , caspase-3, and caspase-3-like (caspase-3, -6, and -7) proteases has been the focus of numerous inves tigations. Although the contribution of caspase-l to ap optosis in the central nervous system has not been well established (Nath et aI., 1996a,b; Wang et aI., 1998; Zhi votovsky et aI., 1997) , a number of studies have impli cated caspase-3-like proteases in neuronal apoptotic cell death (Nath et aI., 1996a,b; Pike et aI., 1998b; . In fact, some studies suggest that caspase-3like proteases are activated only in apoptosis but not in necrosis (Wang et aI., 1996b) . Cal pains are calcium activated, neutral, cytosolic cysteine proteases (Nath et aI., 1996b) . Although investigators have historically as sumed that calpain activation resulted in necrotic cell death, several recent investigations have suggested that calpains can also contribute to apoptosis (Nath et aI., 1996a; Pike et aI., 1998b; Squier et aI., 1994) . Impor tantly, calpain activation has been implicated in different models of apoptosis in different cell types including neu rons (Nath et aI., 1996a; Pike et aI., 1998b; Squier et aI., 1994) . A recent study provided evidence of increased calpain and caspase-3 activity in rat cortical and cerebel lar granule neurons challenged with excitotoxins N methyl-D-aspartate (NMDA), 2-amino-3-hydroxy-S methylisoxazole-4-propionic acid, and kainate, although they provided no data on cell death phenotypes (Nath et aI., 1998) . Similarly, Du et aI. (1997) reported that acti vation of caspase-3-related proteases is required for glu tamate-mediated apoptosis in rat cerebellar granule neu rons. However, these authors did not examine calpain activity.
To address these inconsistencies in studies of excito toxic cell death pathways, our laboratory has systemati cally characterized the phenotypic characteristics of apoptotic cell death produced by staurosporine (Pike et aI., 1998b) and necrotic cell death produced by maito toxin (Zhao et aI., 1999) in primary cultures of septohip pocampal neurons. We chose this culture system because the hippocampus is preferentially vulnerable to a number of acute insults including ischemia (Jenkins et aI., 1989) and mechanical trauma (Lyeth et aI., 1990) . The present study represents the first characterization of apoptotic and necrotic cell death after glutamate toxicity in relation to activation of calpain and caspase-3 proteases. Recog nizing that criteria for cell death phenotypes are subject to controversy (Portera-Cailliau et aI., 1997) , we incor porated a number of widely utilized morphological, bio chemical, and molecular criteria to describe cell death characteristics in neurons and glia after glutamate expo sure. Results of this investigation indicate that glutamate can elicit an apoptotic biochemical response not associ ated with apoptotic cell morphology. This result has im portant implications for pharmacological treatment of cell death, even in cases where apoptosis is not thought to play an important role.
MATERIALS AND METHODS

Septohippocampal cultures
Eighteen-day-old rat fetuses were removed from deeply anesthetized dams. Septi and hippocampi were dissected in a dissection buffer (Hanks' balanced salt solution, with 4.2 mmollL bicarbonate, I mmollL pyruvate, 20 mmollL N-2hydroxyethylpiperazine-N' -2-ethanesulfonate, 3 mg/mL bo vine serum albumin, pH 7.25). After rinsing in Dulbecco's modified Eagle'S medium (DMEM), tissue was dissociated by trituration through the narrow pore of a flame-constricted Pas teur pipette. Dissociated cells were resuspended in DMEM with 10% fetal calf serum and plated on 24-well polY-L-lysine coated plastic culture plates or 12-mm German glass (Erie Sci entific Co., Portsmouth, NH, U.S.A.) at a density of 4.36 x 10 5 cells/mL. Cultures were maintained in a humidified incubator in an atmosphere of 5% CO2 at 3rc. After 5 days in culture, the medium was changed to DMEM with 5% horse serum. Subsequent medium changes were carried out three times a week. By day 10 in vitro, astrocytes formed a confluent mono layer beneath morphologically mature neurons and experiments were performed.
For neuronally enhanced cultures, hippocampi and septi were dissected and dissociated as described above. Dissociated cells were resuspended in DMEM and plated on 24-well poly L-Iysine-coated plastic culture plates at a density of 4.36 x 10 5 cells/mL. Cultures were maintained in a humidified incubator in an atmosphere of 5% CO2 at 37°C. Medium was changed three times a week; however, only 50% of the medium was changed each time to enhance neuronal survival.
Pharmacological treatment of septohippocampal cells
Glutamate. Ten-day-01d mixed septohippocampal cultures were challenged with 1.0, 2.0, or 4.0 mmollL glutamate in DMEM (serum-free), and cell viability was monitored at vari ous postinjury time points (n = 10 wells!condition). Similar glutamate concentrations have been used in mixed (Kure et aI., 1991) and neuronal (Ikeda et aI., 1996) studies. To assess the contribution of glia to differences in sensitivity to glutamate toxicity, neuron ally enhanced septohippocampal cultures were also incubated in varying concentrations of glutamate (I f.LmollL to 2.0 mmol/L) for 24 hours (n = 3 wells/condition). Glutamate was added directly to the medium for the entire duration of experiments. Experiments were performed on day lOin vitro as sensitivity of mixed septohippocampal cultures to glutamate does not differ between 10 and 15 days in vitro (data not shown).
N-Methyl-D-aspartate receptor antagonism, inhibition of calpain and caspase activation, and protein synthesis inhibi tion. Sister cultures were pretreated I hour before, and co treated during, the glutamate challenge, with varying doses of the NMDA antagonist MK-801 (RBI, Natick, MA, U.S.A.; 10 to 500 f.LmoI/L), calpain inhibitor II (N-acetyl-Leu-Leu methiony1; 5 to 100 f.Lmo11L; Boehringer Mannheim, India-napolis, IN, U.S.A.), the pan-caspase inhibitor carbobenzoxy Asp-CH2-OC(O)-2,6-dichlorobenzene (Z-D-DCB; 30 to 300 J.LmoIlL; Bachem, King of Prussia, PA, U.S.A.), or the protein synthesis inhibitor cycloheximide (I J.Lg/mL; Sigma, St. Louis, MO, U.S.A.). All inhibitors were administered in DMEM (n = 3 wells/condition). We and others have used these concentra tions to provide inhibition of NMDA receptor-mediated toxic ity (Carroll et aI., 1996) , cal pain activation (Kampfl et aI., 1996; Pike et aI., 1998b) , caspase-3-like protease activity (Nath et aI., 1996a,b; Pike et aI., 1998b) , and protein synthesis (Mar tin et aI., 1988; Pike et aI., 1998b) , respectively. As noted below, experimental procedures allowed independent assess ments of whether drugs used in this study inhibited activation of calpains and caspase-3-like proteases inferred by a-spectrin proteolysis.
Chemical inducers of apoptotic or necrotic cell death phe notypes. To provide comparisons of glutamate toxicity with classic apoptotic and necrotic profiles, cultures were treated with the general protein kinase inhibitor staurosporine or mai totoxin, a potent marine toxin that activates both voltage sensitive and receptor-operated calcium channels. Ten-day-old septohippocampal cultures were challenged with 0.5 J.Lmol/L staurosporine for 24 hours, a dose and duration that we have previously confirmed produce apoptotic but not necrotic neu ronal cell death in this in vitro system (Pike et aI., 1998b) . The production of apoptotic cell death by staurosporine is associ ated with activation of both caspase-3 and calpain proteases, and staurosporine-induced apoptosis can be attenuated by cal pain or caspase inhibitors (Pike et aI., 1998b) . Cultures were also treated with maitotoxin (0.1 nmollL for I hour), a dose and duration that we have previously confirmed produce an exclu sively necrotic-like cell death profile in neurons and glia and are associated with calpain but not caspase-3 activation (Zhao et aI., 1999) .
Morphological and enzymatic assessments of cell damage
Fluorescein diaceiate and propidium iodide assay oj cell viability. Fluorescein diacetate (FDA) and propidium iodide (PI) dyes were used to assess cell viability at various times between 1 and 72 hours after glutamate incubation. Fluorescein diacetate enters normal cells and emits a green fluorescence when it is cleaved by esterases. Once cleaved, FDA can no longer permeate cell membranes. Propidium iodide is an intra vital dye that is normally excluded from cells. After injury, PI penetrates cells, binds to DNA in the nucleus, and emits a red fluorescence. This technique is commonly used to quantitate cell injury (Jones and Senft, 1985) .
A stock solution of FDA was prepared by dissolving 20 mg/mL in acetone. A PI stock solution was prepared by dis solving 5 mg/mL in Ix phosphate-buffered saline (PBS) (Jones and Senft, 1985) . The FDA and PI working solutions were freshly prepared by adding 10 J.LL of the FDA and 3 J.LL of PI stock to lO mL of Dulbecco's PBS. Two hundred microliters per well of FDNPI working solution was added directly to the cells. Cells were stained for 3 minutes at room temperature. Stained cells were examined with a fluorescence microscope equipped with epi-illumination, bandpass 450-to 490-nm ex citer filter, 510-nm chromatic beam splitter, and a long-pass 520-nm barrier filter. This filter combination permitted both green and red fluorescing cells to be seen simultaneously. Cell viability can be determined because this procedure results in the nuclei of dead cells fluorescing red and the cytoplasm of living cells fluorescing green. Cell loss was calculated in 100x fields (five sequential lOOx fields were counted and averaged J Cereb Blood Flow Metah, Vol. 20, No. 3. 2000 per well) for three wells in each experiment as a percentage of total cell number.
Hoechst staining ojapoptotic nuclei. After overnight fixation in 4% paraformaldehyde at 4°C, cells grown on German glass were washed three times with PBS and labeled with I J.Lg/mL of the DNA dye Hoechst 33258 (bis-benzamide; Sigma) in PBS. Cells were incubated for 5 to 10 minutes at room tem perature, rinsed with PBS, and mounted with crystal-mount medium (Biomeda, Foster City, CA, U.S.A.). Cells were ob served and photographed on a phase and fluorescence micro scope with a UV2A filter.
Determination oj'lactate dehydrogenase activity Lactate de hydrogenase (LDH) activity assessed cell viability (Koh and Choi, 1987) in experiments examining the effects of NMDA receptor antagonism and inhibition of calpain and caspase pro teases and protein synthesis. Lactate dehydrogenase released from damaged cells was measured by standard kinetic assay for pyruvate (Boehringer Mannheim). An increase in the amount of dead or plasma membrane-damaged cells results in an increase of the LDH enzyme activity in the culture supernatant detected by colorimetric measurements. In brief, 200 J.LL of culture me dium was removed from each well and centrifuged at 5,000 g for 5 minutes. One hundred microliters of supernatant was transferred to each well of a 96-well flat bottom plate, and 100 J.LL of detection reagent was added. The plate was covered with foil and incubated on a shaker for 30 minutes at room tempera ture. The absorbance of samples was measured at 490 nm using Bio-Rad model 450 microplate reader (Hercules, CA, U.S.A.).
DNA fr agmentation assay
DNA gel electrophoresis was performed as described previ ously (Gong et aI., 1994) . Cells were collected by centrifuga tion at 3,000 g for 5 minutes, fixed in suspension in 70% cold ethanol, and stored in the fixative at -20°C for 24 to 72 hours, Cells were centrifuged at 800 g for 5 minutes, and the ethanol was thoroughly removed. Cell pellets were resuspended in 40 J.LL of phosphate/citrate buffer consisting of 192 parts of 0.2 mollL Na2HP04 and 8 parts of 0.1 mollL citric acid (pH 7.8) at room temperature for 1 hour. After centrifugation at 1,000 g for 5 minutes, the supernatant was transferred to new tubes and concentrated by vacuum in a SpeedVac concentrator for 15 to 30 minutes. Three microliters of 0.25% Nonidet P-40 in dis tilled water was added, followed by 3 J.LL of DNase-free RNase (I mg/mL). After 30-minute incubation at 37°C, 3 J.LL of pro teinase K (I mg/mL) was added, and the extract was incubated for an additional 30 minutes at 37°C. After the incubation, 1 J.LL of 6x loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF, and 30% glycerol in water) was added, the entire content of the tube was transferred to a 1.5% agarose gel, and electrophoresis was performed in I x Trislboric acid/ethylene diaminetetraacetate solution (0.1 mollL Tris, 0.09 mollL boric acid, and 1 mmol/L ethylenediaminetetraacetate, pH 8.4) at 40 V for 2 hours. The DNA was visualized and photographed under ultraviolet light after staining with 5 J.Lg/mL ethidium bromide.
Assessment of <x-spectrin degradation by calpain and caspase-3
Because the cytoskeletal protein a-spectrin contains se quence motifs preferred by both calpains and caspase-3 prote ases, activation of these two protease families can be assessed concurrently by immunoblot identification of calpain and/or caspase-3 signature cleavage products. Although both calpains and caspases produce an initial fragment of nearly identical size (150 kDa), calpains further process a-spectrin into a distinctive breakdown product (BDP) of 145 kDa (Harris et aI., 1988 ; Nath et a!., I 996a,b), whereas caspase-3 produces a unique 120-kDa BDP .
Sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting. After each experiment, cells were har vested from five identical culture wells, collected in 15-mL centrifuge tubes, and centrifuged at 3,000 g for 5 minutes. Medium was removed, and the cells were rinsed with Ix PBS. Cells were lysed in ice-cold homogenization buffer [20 mmollL 1,4-piperazinediethanesulfonate (pH 7.6), I mmollL ethylene diaminetetraacetate, 2 mmollL ethyleneglycol-bis-([3aminoethyl ether)-N,N,N' ,N' -tetraacetate, I mmollL dithio threitol, 0.5 mmollL phenylmethylsulfonyl fluoride, 50 j.l.g/mL leupeptin, and 10 j.l.g/mL each of 4-(2-aminoethyl)benzenesul fonyl fluoride, aprotinin, pepstatin, Na-p-tosyl-L-Iysine chI oro methyl ketone, and N-tosyl-L-phenylalanine chloromethyl ke tone] for 30 minutes and sheared through a 1.0-mL syringe 15 times with a 25-gauge needle. Protein content in the samples was assayed by the Micro bicinchroninic acid method (Pierce, Rockford, IL, U.S.A.). For protein electrophoresis, equal amounts of total protein (30 j.l.g) were prepared in 2x loading buffer containing 0.25 mollL Tris (pH 6.8), 0.2 mollL dithio threitol, 8% sodium dodecyl sulfate, 0.02% bromophenol blue, and 20% glycerol and heated at 95°C for 10 minutes. Samples were resolved in a vertical electrophoresis chamber using a 4% stacking gel over a 6.5% acrylamide resolving gel for I hour at 200 V. For immunoblotting, separated proteins were laterally transferred to nitrocellulose membranes (0.45 j.l.m) using a transfer buffer consisting of 0.192 mollL glycine and 0.025 mollL Tris (pH 8.3) with 10% methanol at a constant voltage of 100 V for I hour at 4°C. Blots were blocked overnight in 5% nonfat milk in 20 mmollL Tris, 0.15 mollL NaCI, and 0.005% Tween 20 at 4°C. Gels and nitrocellulose membranes were stained with Coomassie Blue and Ponceau Red, respectively (Sigma) to confirm that equal amounts of protein were loaded in each lane.
Antibodies and immunolabeling. lmmunoblots were probed with an anti-a-spectrin monoclonal antibody (Affiniti Research Products, Mamhead, U.K.; catalog no. FG 6090, clone AA6) that detects intact a-spectrin (M, = 240 kDa) and 150-, 145-, and 120-kDa BDPs. After incubation with primary antibody (1:4,000) for 2 hours at room temperature, blots were incubated in peroxidase-conjugated sheep anti-mouse IgG for I hour (I: 10,000). Enhanced chemiluminescence reagents (ECL kit; Amersham) were used to visualize the immunolabeling on Hy perfilm (Hyperfilm ECL; Amersham, Piscataway, NJ, U.S.A.).
Hoechst 33258 staining in glial or neuronal cell types
To determine the effects of glutamate on astroglial and neu ronal cell types, cultures were labeled immunocytochemically with glial fibrillary acidic protein (GFAP; for astroglia) or mi crotubule-associated protein-2 (MAP-2) and neuronal nuclear marker (NeuN; for neurons) and counterstained with Hoechst 33258. Microtubule-associated protein-2 labels primarily den drites, whereas NeuN is a neuronal nuclear marker. Cultures were fixed in 4% paraformaldehyde for I hour at 4DC and washed and stored in Ix PBS. Cultures were permeabilized with 0.3% Triton X-100 for 30 minutes and blocked with 1% normal horse or goat serum at room temperature for \ hour, followed by incubation with GFAP (\:\,000) or MAP-2 and NeuN (1: I ,000) antibody overnight at 4 DC. Cultures were washed in \ x PBS and incubated in horseradish peroxidase conjugated goat anti-rabbit IgG (for GFAP) or sheep anti mouse IgG (for MAP-2 and NeuN) (Cappel [Durham, NC, U.S.A.]; I: 1,0(0) for I hour. Cultures were washed three times in Ix PBS, and diaminobenzidine (Vector, Burlingame, CA, U.S.A.) was used to visualize the reaction. After incubation in diaminobenzidine, the reaction was stopped in tap water, and cultures were counterstained with Hoechst 33258 for 5 minutes. After a final wash, cells were mounted and covers lipped with Cytoseal 280 mounting medium (EMS, Fort Washington, PA, U.S.A.). Each slide was observed and photographed in the same field using light (for immunolabeled cells) and fluores cence (for Hoechst 33258-labeled cells) microscopy. A phase contrast microscope (Axiovert 135) was used to distinguish the glial and neuronal cell layers.
Statistical analyses
Each experiment was performed three times, and data were evaluated by analysis of variance with a post hoc Tukey test. Values are given as means ± I SD. Differences were considered significant at P < 0.05.
RESULTS
Effects of glutamate on septohippocampal glial-neuronal co-cultures
Dose-and time-dependent cell death. An initial series of experiments was conducted to determine dose response relationships between glutamate concentrations and cell viability at various times after incubation with the excitotoxin. Propidium iodide and FDA were used to assess cell death and membrane integrity. Exposure of mixed septohippocampal cultures to 1.0, 2.0, and 4.0 mmol/L glutamate induced a dose-dependent cell death with an LDso of 2.0 mmollL glutamate after 24-hour incubation ( Fig. I A) . The percentages of cells that stained for PI after exposure to 2.0 mmollL glutamate were 14.6% at 1 hour, 17.5% at 3 hours, 27.l % at 6 hours, and 51.3% at 24 hours ( Fig. I A) . A one-way analysis of variance performed on these data revealed a significant effect of group (F3•18 = 13.13, P < 0.0001). Post hoc analyses showed significant increases in cell death after 1.0 mmol/L glutamate for 24 hours and at all time points using 2.0 and 4.0 mmol/L glutamate com pared with control cells. Incubation with 2.0 mmol/L glutamate for 24 hours was used for most subsequent experiments, unless stated otherwise. Similar glutamate concentrations have been used to study cell death in other glial-neuronal co-culture systems (Kure et ai., 1991 ; also see Ikeda et ai., 1996) . The LDso for gluta mate in neuronally enhanced cultures (-10 J-LmollL; Fig.   IB ) is similar to values reported for glutamate in other neuronally enhanced cultures (Manev et a!., 1991) . Uni variate analysis of these data also showed a significant effect of group (F7.16 = 116, P < 0.0001), and post hoc analyses revealed significant increases in cell death at all concentrations tested.
Morphological responses to glutamate challenge. Glu tamate-treated septohippocampal cultures underwent morphological alterations in cell structure that were char acteristic of neither apoptosis nor necrosis (Figs. 2 and  3) . mmollL glutamate (Fig. 2D) , PI staining detected greater nuclear swelling than observed in maitotoxin-induced necrosis (Fig. 2B ) or staurosporine-induced apoptosis (Fig. 2C ). In addition, there was no evidence of apoptotic membrane blebbing or necrotic enlargement of cell bod ies, as seen in cells injured with staurosporine ( Fig. 2C ) or maitotoxin (Fig. 2B) , respectively. The FDA/PI stain ing of uninjured control cultures showed healthy FDA positive cell bodies and few cells stained with PI ( Fig.  2A ). Hoechst staining of nuclear chromatin further charac terized cell death characteristics of glutamate toxicity in J Cereb Blood Flow Metab. Vol. 20. No. 3. 2000 septohippocampal cultures (Fig. 3) . Treatment with mai totoxin (0.1 nmollL) for 1 hour produced necrotic cell death (Figs. 3B and 3F) that was characterized by a pyk notic but even distribution of chromatin staining. Nuclei of maitotoxin-treated cells appeared smaller, with more condensed chromatin, yielding brighter Hoechst staining. Consistent with necrotic-like cell death, Hoechst staining did not detect chromatin marginization to the nuclear envelope, formation of apoptotic bodies, or other pheno typical evidence of apoptotic-like profiles. In contrast, treatment with staurosporine (0.5 J.,Lmol!L) for 24 hours (Figs. 3C and 3G) produced increased condensation and marginization of chromatin to the nuclear envelope as well as formation of dense apoptotic bodies. Treatment with glutamate (2.0 mmollL) for 6 hours (Figs. 3D and 3H) produced morphological alterations that differed from the classic necrotic and apoptotic changes observed after maitotoxin or staurosporine exposure. After gluta mate treatment, cell nuclei were enlarged and eccentri cally shaped. In addition, chromatin was aggregated in a diffusely speckled pattern throughout the entire nucleus. Chromatin clumping along nuclear margins and evidence of apoptotic body formation were not observed in gluta mate-treated cells. Additional experiments examined changes in nuclear morphology after I hour, 24 hours, 3 days, or 5 days of incubation with 2.0 mmollL glutamate. Hoechst staining revealed that there were no apparent changes in nuclear morphology over this 5-day period (data not shown).
DNA fragmentation. Endonuclytic DNA fragmenta tion can occur independently of chromatin condensation (Lin and Chou, 1992) . Thus, a DNA fragmentation assay was used to determine whether DNA alterations in sep tohippocampal cultures assessed by Hoechst 33258 staining were associated with endonuclease activity. No dose of glutamate tested (0.5, 1.0, 2.0, or 4.0 mmol/L) produced evidence of DNA laddering after 24 hours of incubation (Fig. 4) or for any other length of incubation tested (15 minutes to 5 days; data not shown). Treatment with maitotoxin also failed to produce DNA ladders, a profile consistent with necrotic cell death. In contrast, treatment with staurosporine produced readily detectable nucleosomal-size DNA fragments characteristic of many apoptotic model systems.
Induction of cell death in both neurons and astroglia in septohippocampal cultures by glutamate. To identify the type of cell (that is, astroglial versus neuronal) in jured by glutamate treatment, cells were stained with Hoechst 33258 and immunolabeled with anti-MAP-2 and anti-NeuN to identify neurons (Fig. 5 ) or anti-GFAP to identify astroglia (Fig. 6 ). After incubation with glu tamate (2.0 mmol/L) for 24 hours (Figs. 5C and 5D ), the number of NeuN-immunopositive neurons was markedly reduced as compared with control cultures (Figs. SA and 5C). In addition, broken dendritic processes were appar- Treatment with glutamate (2.0 mmollL) for 6 hours. After gluta mate treatment, PI staining detected greater nuclear swelling than observed in maitotoxin-induced necrosis (B) or staurospo rine-induced apoptosis (C). In addition, there was no evidence of apoptotic membrane blebbing or necrotic enlargement of cell bodies. Bar = 5 �m. ent as well as loss of MAP-2 immunoreactivity (Fig. SC) . The MAP-2 immunohistochemistry also detected promi nent dendritic beading after glutamate treatment (Fig.  SC) . Hoechst staining in injured neurons revealed chro matin aggregation in a diffusely speckled pattern with no chromatin clumping along nuclear margins (Fig. SD) . Incubation with glutamate (2.0 mmollL) for 24 hours resulted in glial cell death (Figs. 6C and 6D ) that was associated with cell shrinkage and membrane folding. These changes ultimately resulted in complete cell de tachment and loss of confluence of the glial monolayer. After injury, Hoechst staining revealed DNA aggregation in a diffusely speckled pattern (Fig. 6D ) in some GFAP positive cells (Fig. 6C ). Hoechst staining in injured glia revealed a similar nuclear profile to that observed in glu tamate-treated neurons (Fig. SD vs. Fig. 6D ).
Calpain and caspase-3 proteolysis of a-spectrin
Proteolysis of a-spectrin into lSO-kDa, calpain specific 14S-kDa, and caspase-3-specific 120-kDa BDPs was examined after incubation with varying doses of glutamate (1.0, 2.0, and 4.0 mmol/L) for 3, 6, or 24 hours (Fig. 7) . Magnitudes of calpain and caspase-3 activation were dependent on concentrations of glutamate and du rations of incubation. In general, every dose of glutamate tested produced prominent calpain activation. Lower glu tamate concentrations (1.0 and 2.0 mmollL) produced modest but sustained caspase-3 activation. The highest dose of glutamate (4.0 mmol/L) produced prominent caspase-3 activation after 6 hours of incubation. Cell viability assessments. Lactate dehydrogenase re lease assessed cell viability 6 hours after incubation with 2.0 mmol/L glutamate alone or in combination with varying doses of the NMDA receptor antagonist MK-801 (10 to SOO f..L moIlL), calpain inhibitor II (S to 100 f..L moll L), and the pan-caspase inhibitor Z-D-DCB (30 to 300 f..L moI/L; Fig. 8) . A significant effect of group was shown by a one-way analysis of variance for MK-801 (F6 • 14 = 89.0S, P < 0.0001) and Z-D-DCB (F6,1 4 = 82.77, P < 0.0001) but not for calpain inhibitor II (FS , 12 = 3.03, P = 0.OS3S). Post hoc analyses revealed significant dif ferences in LDH release between glutamate-injured and control cells and between glutamate-injured cells and cells treated with all MK-801 doses, 2S f..L mol/L calpain inhibitor II, and 30 to 200 f..L mol/L Z-D-DCB. MK-801 provided optimal protection at 100 f..L mol/L concentra tions, inferred by LDH release (Fig. 8A) ; calpain inhibi tor II provided minimal protection against cell death at 2S f..L mo11L concentrations (Fig. 8B) ; and Z-D-DCB pro vided optimal protection at SO to 100 f..L mollL concen trations (Fig. 8C) . a.-Spectrin proteolysis. Western blots examined prote olysis of a.-spectrin into 150-kDa, calpain-specific 145-kDa, and caspase 3-specific 120-kDa BDPs detected af ter 6 hours of glutamate incubation alone (2.0 mmol/L) or in combination with optimal doses of calpain inhibitor II (25 /-LmollL), MK-801 (100 /-LmoI/L), Z-D-DCB (50 /-LmollL), and cycloheximide (I /-Lg/ml). The effects of these drugs on a.-spectrin proteolysis were compared with their effectiveness in protecting against glutamate cell death, inferred by LDH release (Fig. 9 ). Glutamate treatment was sometimes associated with an additional lower molecular mass band, suggesting further process ing of a.-spectrin not observed in control cultures. A one-way analysis of variance revealed a significant effect of group (FS.12 = 193, P < 0.0001). Post hoc analyses showed significant differences between glutamate injured and control cells and between glutamate-injured cells and cells treated with calpain inhibitor II, Z-D DCB, or MK-801. Although calpain inhibitor II signifi cantly inhibited calpain activation, inhibition only mini mally reduced LDH release. The pan-caspase inhibitor Z-D-DCB significantly reduced caspase-3 activation as well as LDH release. The protein synthesis inhibitor cy cloheximide failed to block calpain or caspase-3 activa tion or to reduce LDH release. MK-801 significantly reduced calpain activation as well as LDH release.
DISCUSSION
The present study provides the first systematic exami nation of cell death phenotypes associated with gluta mate toxicity in primary mixed neuronal cultures. The study also provides the first concurrent assessment of potential contributions of two important families of cys teine proteases, calpains and caspases, to glutamate induced cell death in any model system. Our data suggest that activation of caspase-3 could be an impor tant mediator of glutamate toxicity. Activation of calcium-dependent proteases also contributes to gluta mate toxicity, although calpain inhibition was not as effective at providing protection against cell death as was Z-D-DCB. However, Z-D-DCB is a pan-caspase inhibitor, and thus its more robust protection may be due to inhibition of caspases other than caspase-3. Im portantly, glutamate-induced cell death did not resemble apoptotic or necrotic phenotypes produced in this same cell system by chemical inducers of apoptosis or necro sis.
Glutamate toxicity in mixed primary septohippocampal cell cultures Dose-response analyses showed that 2.0 mmol/L glu tamate produced -50% cell death in mixed neuronal glial cultures after 24 hours of incubation. Glutamate induced cell death in the present study was inferred by both FDA/PI staining and LDH release. In separate stud ies, we have confirmed that these two measures provide congruent assessments of loss of cell viability (data not shown). Researchers usually find that neuronally en hanced cultures are more sensitive to glutamate toxicity than mixed neuronal-glial cultures (Adamec et a!., 1998; Manev et aI., 1991) , although some investigations have used millimolar concentrations to study glutamate exci totoxicity in neurons (Ikeda et aI., 1996) . Higher concen trations of glutamate required in mixed culture systems are largely attributable to the formation of a confluent monolayer of astrocytes on which the neurons grow. As trocytes act as glutamate sinks, aminating this neuro transmitter to form glutamine (Murphy and Horrocks, 1994) . Investigators often report that astrocytes can pro tect neurons from glutamate excitotoxicity (Sass et a!., 1993) .. We confirmed the contribution of astrocytes to reduced glutamate toxicity in our culture system by dem onstrating that neuronally enhanced septohippocampal cultures have dramatically increased sensitivity to gluta mate toxicity (Fig. IB) .
Major glutamate receptors studied to date are ex- pressed in hippocampal neurons within the first 10 days in culture, with the exception of metabotropic receptors, which constitute <1 % of mature neurons (Craig et aI., 1993) . This observation is consistent with experiments in our laboratory showing that sensitivity of mixed septo hippocampal cultures to glutamate excitotoxicity did not differ between lO and 15 days in vitro (data not shown). However, full maturation and precise localization of glu tamate receptor SUbtypes at synapses can evolve over > 15 days (Craig et aI., 1993) . Future studies could more systematically examine relationships between the devel opment of glutamate synapses in the hippocampus and mechanisms of glutamate toxicity.
In the present study, glutamate toxicity was observed both in neurons and in glia. Although investigations have assessed glutamate toxicity in neuronally enhanced (Ad amec et aI., 1998; Ikeda et aI., 1996; Manev et aI., 1991) or astrocytic (Manev et aI., 1991) cultures separately, to our knowledge, no studies have compared the morpho pathological changes after glutamate toxicity in neuronal and glial mixed cultures. There are reports of excitotoxic glial injury in vivo (Bolton and Perry, 1998; Matyja, J Cereb Blood Flow Metab, Vol. 20, No. 3, 2000 1986). However, other in vivo (Portera-Cailliau et aI., 1995) and hippocampal slice (Siman and Card, 1988) studies failed to detect glial injury.
Proteolytic regulation of glutamate-induced cell death
Calpains and caspase-3 process the cytoskeletal pro tein cx-spectrin (280 kDa) into distinctive proteolytic fragments of 145 kDa by calpains (Harris et aI., 1988; Nath et aI., 1996a,b) and 120 kDa by caspase-3 (Wang et aI., 1998) .. Whereas the specificity of the 145-kDa frag ment for cal pain is well accepted, there has been some controversy regarding the specificity of caspase-3specific BDPs. However, the specificity of the caspase-3-generated 120-kDa cx-spectrin product is well charac terized. Recently, Wang and colleagues (1998) reported that when cell lysates were digested for 1 hour with recombinant caspase-l, -2, -3, -4, -6, or -7, only caspase-3 produced accumulation of the 120 kDa cx-spectrin fragment. Moreover, our laboratory and oth ers have successfully used this technique to detect inde pendent and/or concurrent calpain/caspase-3 activation in cell cultures (Nath et aI., 1996a (Nath et aI., ,b, 1998 Pike et aI., 1998b; and in vivo after traumatic brain injury (Pike et aI., 1998a) . In addition, the caspase-3-generated 120-kDa a-spectrin fragment has been shown to be an identifying marker of apoptotic cell death Glutamate Insult
in a number of cell lines and cell culture systems (Martin et aI., 1995; Nath et aI., 1996b Nath et aI., , 1998 Pike et aI., 1998b; Wang et aI., 1998) . In the present study, all three con centrations of glutamate produced robust cal pain mediated processing of a-spectrin that was especially <J a-spectrin Z-O-OCB provided significant protection against cell death with 30 to 200 j.Jmol/L doses. The optimal dose was 50 to 100 j.JmollL (P < 0.001). Calpain inhibitor II provided only minimal protection at 25 j.Jmol/L (P < 0.05). *P <0.05, ***P < 0.001. apparent 6 hours after injury and sustained for at least 24 hours. Caspase-3 activation was less pronounced and showed some differences associated with glutamate con centrations. Other investigators have reported calpain ac tivation produced by glutamate in hippocampal (Adamec et aI., 1998) and cerebellar (Manev et aI., 1991) culture systems, and increased caspase-3 activation has been ob served after glutamate treatment in cerebellar granule neurons (Du et aI., 1997) . The pan-caspase inhibitor Z D-DCB produced significant reduction in caspase-3 ac tivation and cell death, inferred by LDH release, sug gesting that caspase activation importantly contributes to glutamate-mediated cell death. As Z-D-DCB is not spe cific for caspase-3, some protection may be attributable to inhibition of other caspases such as caspase-l. How ever, calpain inhibitor II, at concentrations that inhibited calpain activation, provided less robust protection against glutamate-induced cell death. Other investigators have reported that calpain inhibition does not protect against glutamate-induced cell death either in cultured hippocampal neurons (Adamec et aI., 1998) or in cer ebellar granule cells (Manev et aI., 1991) . However, other in vitro studies have reported protective effects of calpain inhibitors on excitotoxic cell death of cerebellar neurons employing a ligand of non-NMDA receptors (Wang et a!., I 996a), in contrast to exogenous glutamate treatment, which was employed in the present study. The relatively modest levels of protection by calpain inhibi tion against excitotoxic cell death in vitro are surprising in view of a considerable body of evidence showing significant protective effects of calpain inhibitors in in vivo models of cerebral ischemia and traumatic brain injury (Kampfl et a!., 1997; Posmantur et aI., 1997; Wang and Yuen, 1997) . It is possible that calpain inhi bition provides suboptimal protection because pathologi cal activation of calpain occurs downstream of other events that could contribute to glutamate-induced cell death, including activation of other calcium-dependent enzymes (for example, lipases and phosphatases) (Hom ayoun et aI., 1997). There may also be important differ ences in pathogenic stimuli in complex in vivo insults versus glutamate toxicity in vitro that could significantly influence cell death mechanisms in ways that are cur rently poorly understood. MK-801 produced significant, although incomplete, reductions in LDH release resulting from glutamate ex citotoxicity at a concentration similar to those reported by others (Adamec et aI., 1998) . As prolonged exposure to glutamate might possibly produce toxicity by recep tor-independent mechanisms such as competitive inhibi tion of cysteine uptake (Murphy et aI., 1990) , significant protection by MK-801 confirms a receptor-mediated mechanism for glutamate toxicity in hippocampal neu ronal cultures. In addition, MK-801 reduced calpain ac tivation, inferred by spectrin proteolysis, confirming pre- ing proteolysis of a-spectrin into 150-kOa, cal pain-specific 145-kOa, and caspase-3-specific 120-kOa break down products (BOPs) detected after 6 hours of glutamate treatment alone (2.0 mmol/L) or in combination with op timal doses of calpain inhibitor II (CI-II ; 25 J.lmoI/L) , MK-801 (100 J.lmoI/L) , car bobenzoxy-Asp-CH2-0C( 0)-2, 6dichlorobenzene (Z-O-OCB; 50 J.lmoll L), and cycloheximide (CHX; 1 J.lg/mL). Glutamate treatment resulted in accu mulation of cal pain-and caspase-3mediated BOPs. Glutamate treatment was sometimes associated with an ad ditional lower molecular mass band, suggesting further processing of a-spectrin not observed in control cUl tures. Calpain (CI-II) and caspase (Z O-OCB) inhibition reduced the accu mulation of their respective BOPs, whereas cycloheximide had no effect. MK-801 reduced calpain activation but had no apparent effect on caspase-3 activation. (Bottom) Effects of various doses of drugs on cell viability assessed by lactate dehydrogenase (LOH) release 6 hours after incubation with glutamate alone or in combination with optimal doses of drugs. Cal pain inhibitor II (P < 0.05), Z-O-OCB (P < 0.001), and MK-801 (P < 0.001) significantly reduced LOH release after glutamate treatment. * P < 0.05, *** P < 0.001.
vious reports that activation of NMDA receptors is nec essary for calpain activation (Adamec et ai., 1998) .
Characterization of cell death phenotypes in nervous system
Although phenotypic characterization of cell death may remain a useful adjunct strategy, ultimately cell death mechanisms must be defined by biochemical and molecular mechanisms. Activation of these biochemical and molecular mechanisms may depend on cell death signal and cell type, and different mechanisms may be activated separately or concurrently. Future studies should consider the possibility of heterogeneity in cell death mechanisms and associated cell death phenotypes.
